Pechlivanoglou Lab

Publications

Figure of four boxes that shows the continuous cycle of how paediatric populations go from healthy to death based on health decisions

2022

Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without down syndrome.
Athale U, Sutradhar R, Breakey VR, Li Q, Bassal M, Gibson P, Patel S, Wheaton L, Pole JD, Mittman N, Pechlivanoglou P, Gupta S. Pediatric Blood Cancer. 2022 Oct; 69(10):e29829.
A tutorial on time-dependent cohort state-transition models in R using a cost-effectiveness analysis example.
Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MGM, Pechlivanoglou P, Jalal H. Medical Decision Making. 2022 Sep 16;272989X221121747. [Epub ahead of print]
The impact of provincial lockdown policies and COVID-19 case and mortality rates on anxiety in Canada.
Plett D, Pechlivanoglou P, Coyte PC. Psychiatry Clinical Neuroscience. 2022 Sep;76(9):468-474.
Interpreting and assessing confidence in network meta-analysis results: An introduction for clinicians.
Yang A, Pechlivanoglou P, Aoyama K. Journal of Anesthesia. 2022 Aug;36(4):524-531.
Clinical health outcomes of siblings of children with chronic conditions: A systematic review and meta-analysis.
Martinez B, Pechlivanoglou P, Meng D, Traubici B, Mahood Q, Korczak D, Colasanto M, Mahant S, Orkin J, Cohen E. Journal of Pediatrics. 2022 Jul 8;S0022-3476(22)00619-9. [Epub ahead of print]
Prioritizing research in an era of personalized medicine: The potential value of unexplained heterogeneity.
Heath A, Pechlivanoglou P. Medical Decision Making. 2022 Jul;42(5):649-660.
An introductory tutorial on cohort state-transition models in R using a cost-effectiveness analysis example.
Alarid-Escudero F, Krijkamp EM, Enns EA, Yang A, Hunink M, Pechlivanoglou P, Jalal H. Medical Decision Making. 2022 Jun 30;272989X221103163. [Epub ahead of print]
The trend in costs of tertiary-level Neonatal Intensive Care for neonates born preterm at 22 ^0/7-28 ^6/7 weeks of gestation from 2010 to 2019 in Canada.
Yeung T, Rios JD, Beltempo M, Khurshid F, Toye J, Ojah C, Zupancic JAF, Lee SK, Pechlivanoglou P, Shah PS, Canadian Neonatal Network (CNN) and the Canadian Preterm Birth Network (CPTBN) Investigators. The Journal of Pediatrics. 2022 Jun;245:72-80.e6.
Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.
Gajic-Veljanoski O, Li C, Schaink A, Guo J, Shehata N, Charames G, Devrijer B, Clarke G, Pechlivanoglou P, Okun N, Kandel R, Dooley J, Higgins C, Sikich N, Ng V, de Vrijer B. Transfusion. 2022 May;62(5):1089-1102.
Efficacy and safety of adalimumab and infliximab for non-infectious uveitis.
Tai F, Far PM, Pechlivanoglou P, Ramsay L, Georgakopoulos JR, Sander B, Derzko-Dzulynsky LA, Felfeli T. Ophthalmology. 2022 Mar;129(3):357-359.
Diagnostic accuracy of teleretinal screening for detection of diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysis. Far PM, Tai F, Ogunbameru A, Pechlivanoglou P, Sander B, Wong DT, Brent MH, Felfeli T. BMJ Open Ophthalmology. 2022 Feb 10;7:e000915. doi: 10.1136/bmjophth-2021-000915. eCollection 2022.
Obsessive compulsive disorder and response inhibition: Meta-analysis of the stop-signal task.
Mar K, Townes P, Pechlivanoglou P, Arnold P, Schachar R. Journal of Psychopathology and Clinical Science. 2022 Feb;131(2):152-161.
Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma.
Rios JD, Velummailum R, Bennett J, Nobre L, Tsang DS, Bouffet E, Hawkins C, Tabori U, Denburg A, Pechlivanoglou P. BMC Pediatrics. 2022 Jan 3;22(1):13.

2021

Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: A simulation study.
Becca JM, Chan KKW, Naimark DMJ, Pechlivanoglou P. BMC Medical Research Methodology. 2021 Dec 18;21(1):282.
Prioritisation and design of clinical trials.
Heath A, Hunink MGM, Krijkamp E, Pechlivanoglou P. European Journal of Epidemiology. 2021 Nov;36(11):1111-1121.
Association of timing of birth with mortality among preterm infants born in Canada.
Rizzolo A, Shah PS, Bertelle V, Makary V, Ye XY, Abenheim HA, Piedboeuf B, Beltempo M, Canadian Neonatal Network (CNN) and Canadian Preterm Birth Network (CTBN) Investigators. Journal of Perinatology. 2021 Nov;41(11):2597-2606.
Dexmedetomidine vs. total intravenous anaesthesia in paediatric emergence delirium: A network meta-analysis.
Petre MA, Levin DN, Englesakis M, Maynes JT, Pechlivanoglou P, Aoyama K. European Journal of Anesthesiology. 2021 Nov 1; 38(11):1111-1123.
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children’s Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
Bassal M, Silva M, Patel S, Gibson PJ, Breakey VR, Athale U, Zabih V, Li Q, Pechlivanoglou P, Pole JD, Mittman N, Sutradhar R, Gupta S. Pediatric Blood & Cancer. 2021 Oct; 68(10):e29141.
The clinical utility of exome and genome sequencing across clinical indications: A systematic review.
Shickh S, Mighton C, Uleryk E, Pechlivanoglou P, Bombard Y. Human Genetics. 2021 Oct; 140(10):1403-1416.
Non-invasive fetal RhD blood group genotyping: A systematic review of economic evaluations.
Gajic-Veljanoski O, Li C, Schaink AK, Guo J, Higgins C, Shehata N, Okun N, de Vrijer B, Pechlivanoglou P, Ng V, Sikich N. Journal of Obstetrics and Gynaecology Canada. 2021 Aug 11; S1701-2163(21)00600-9.
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
Gupta S, Sutradhar R, Li Q, Athale U, Bassal M, Breakey V, Gibson PJ, Patel S, Silva M, Zabih V, Pechlivanoglou P, Pole JD, Mittmann N. European Journal of Cancer. 2021 Jul; 151:126-135.
Mode of delivery and neonatal outcomes in extremely preterm Vertex/nonVertex twins.
Hiersch L, Shah PS, Khurshid F, Masse E, Murphy K, McDonald SD, Carson G, Barrett J, Melamed N, Canadian Neonatal Network (CNN) and the Canadian Preterm Birth Network (CPTBN) Investigators. American Journal of Obstetrics and Gynecology. 2021 Jun; 224(6):613.e1-613.e10.
Automated movement recognition to predict motor impairment in high-risk infants: A systematic review of diagnostic test accuracy and meta-analysis.
Raghuram K, Orlandi S, Church P, Chau T, Uleryk E, Pechlivanoglou P, Shah V. Developmental Medicine & Child Neurology. 2021 June; 63(6):637-648.
A Bayesian response-adaptive dose-finding and comparative effectiveness trial.
Heath A, Yaskina M, Pechlivanoglou P, Rios D, Offringa M, Klassen TP, Poonai N, Pullenayegum E. Clinical Trials. 2021 Feb; 18(1):61-70.
Benefit of antenatal corticosteroids by year of birth among preterm infants in Canada during 2003-2017: A population-based cohort study.
Melamed N, Murphy K, Barrett J, Asztalos E, McDonald SD, Yoon EW, Shah PS, Canadian Neonatal Network (CNN), Canadian Preterm Birth Network (CPTBN) Investigators. BJOG. 2021 Feb; 128(3):521-531.
Costs of neonatal intensive care for Canadian infants with preterm birth.
Rios JD, Shah PS, Beltempo M, Louis D, Mukerji A, Premji S, Shah V, Lee SK, Pechlivanoglou P, Canadian Preterm Birth Network Investigators, Canadian Neonatal Network Investigators. The Journal of Pediatrics. 2021 Feb; 229:161-167.e12.
The intranasal dexmedetomidine plus ketamine for procedural sedation in children, adaptive randomized controlled non-inferiority multicenter trial (Ketodex): A statistical analysis plan.
Heath A, Rios JD, Pullenayegum E, Pechlivanoglou P, Offriga M, Yaskina M, Watts R, Rimmer S, Klassen TP, Coriolano K, Poonai N, PERC-KIDSCAN Ketodex Study Group. Trials. 2021 Jan 6;22(1):15.
Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: A systematic review and meta-analysis.
Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y. Genetics in Medicine. 2021 Jan; 23(1):22-33.

2020

Adaptive randomised controlled non-inferiority multicentre trial (the Ketodex Trial) on intranasal dexmedetomidine plus ketamine for procedural sedation in children: Study protocol.
Poonai N, Coriolano K, Klassen T, Heath A, Yaskina M, Beer D, Sawyer S, Bhatt M, Kam A, Doan Q, Sabhaney V, Offringa M, Pechlivanoglou P, Hickes S, Ali S, KidsCAN PERC iPCT-SPOR Ketodex Study Team.BMJ Open. 2020 Dec 10; 10(12):e041319.
Mode of delivery and neonatal outcomes in extremely preterm Vertex/nonVertex twins.
Hiersch L, Shah PS, Khurshid F, Masse E, Murphy K, McDonald SD, Carson G, Barrett J, Melamed N, Canadian Neonatal Network (CNN) and the Canadian Preterm Birth Network (CPTBN) Investigators. American Journal of Obstetrics and Gynecology. 2020 Dec 9. doi: 10.1016/j.ajog.2020.12.002.
Estimating the risk of SARS-CoV-2 transmission to pediatric anesthesiologists: A microsimulation model.
Aoyama K, Heath A, Yang A, Maynes JT, Petroz G, Robertson J, McDonnell C, Velummailum R, Bond E, Pechlivanoglou P. Canadian Journal of Anesthesiology. 2020 Nov; 67(11):1694-1696.
Early operative management in patients with adhesive small bowel obstruction: Population-based cost analysis.
Behman R, Nathens AB, Pechlivanoglou P, Karanicolas P, Jung J, Look Hong N. The British Journal of Surgery. 2020 Oct; 4(5):914-923.
COVID-19: Adaptation of a model to predicting healthcare resources needs in Valle del Cauca, Colombia.
Iragorri N, Gómez-Restrepo C, Barrett K, Herrera S, Hurtado I, Khan Y, Mac S, Naimark D, Pechlivanoglou P, Rosselli D, Toro D, Villamizar P, Ximenes R, Zapata H, Sander B. Colombia Medica. 2020 Sep 30;51(3):e204534.
Non-steroid or opioid analgesia use for children with musculoskeletal injuries (the No OUCH study): Statistical analysis plan.
Heath A, Yasika M, Hopkin G, Klassen TP, McCabe C, Offringa M, Pechlivanoglou P, Rios JD, Poonai N, Ali S, KidsCAN PERC Innovative Pediatric Clinical Trials No OUCH Study Group. Trials. 2020 Sep 3; 21(1):759.
A pragmatic randomized controlled trial of multi-dose oral ondansetron for pediatric gastroenteritis (the DOSE-AGE study): statistical analysis plan.
Heath A, Rios JD, Williamson-Urquhart S, Pechlivanoglou P, Offringa M, McCabe C, Hopkin G, Plint AC, Dixon A, Beer D, Gouin S, Joubert G, Klassen TP, Freedman SB, PERC-KIDSCAN DOSE-AGE Study Group. Trials. 2020 Aug 24; 21(1): 735. doi: 10.1186/s13063-020-04651-1.
Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study.
Bond E, Abrahamyan L, Krahn M, Gershon A, Krahn M, Li P, Mian R, Mitsakakis N, Sadatsafavi M, To T, Pechlivanoglou P, The Canadian Respiratory Research Network. PLoS One. 2020 Aug 20; 15(8): e0236559.
Multi-dose oral ondansetron for pediatric gastroenteritis: Study protocol for the multi-DOSE oral ondansetron for pediatric acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial.
Freedman S, Williamson-Urquhar S, Heath A, Pechlivanoglou P, Hopkin G, Gouin S, Plint A, Dixon A, Beer D, Joubert G, McCabe C, Finkelstein Y, Klassen P. Trials. 2020 May 27; 21(1): 435.
Determining a Bayesian predictive power stopping rule for futility in a non-inferiority trial with binary outcomes.
Heath A, Offringa M, Pechlivanoglou P, Rios JD, Klassen TP, Poonai N, Pullenayegum E, KidsCAN PERC Innovative Paediatric Clinical Trials Team. Contemporary Clinical Trials Communication. 2020 Apr 8; 18: 100561.
Longer trials of non-operative management for adhesive small bowel obstruction are associated with increased complications.
Fung B, Behman R, Nguyen MA, Nathens AB, Look Hong NJ, Pechlivanoglou P, Karanicolas PJ. Journal of Gastrointestinal Surgery. 2020 Apr; 24(4)890-898.
Health outcomes of parents of children with chronic illness: A systematic review and meta-analysis.
Cohn LN, Pechlivanoglou P, Lee Y, Mahant S, Orkin J, Marson A, Cohen E. Journal of Pediatrics. 2020 Mar; 218:166-177.e2.
Cost-effectiveness of tisagenlecleucel vs standard care in high-risk relapsed pediatric acute lymphoblastic leukemia in Canada.
Furzer J, Gupta S, Nathan PC, Schlechter T, Pole JD, Krueger J, Pechlivanoglou P. JAMA Oncology. 2020 Mar 1; 6(3):393-401.
Hospital resources do not predict accuracy of secondary trauma triage: A population-based analysis.
Tillmann BW, Nathens AB, Guttman M, Pequeno P, Scales DC, Pechlivanoglou P, Haas B. Journal of Trauma and Acute Care Surgery. 2020 Feb; 88(2): 230-241.
A multidimensional array representation of state-transition model dynamics.
Krijkamp EM, Alarid-Escudero F, Enns EA, Pechlivanoglou P, Hunink MGM, Yang A, Jalal HJ. Medical Decision Making. 2020 Feb; 40(2): 242-248.
Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models.
Arrospide A, Ramos-Goñi JM, Pechlivanoglou P, Mar J. Gac SanitGaceta Sanitaria. 2020 Jan-Feb; 34(1): 91-95.
A systematic review and meta-analysis of health utilities in patients with chronic hepatitis C
Saeed YA, Phoon A, Bielecki JM, Mitsakakis N, Bremmer KE, Abrahamyan L, Pechlivanoglou P, Feld JJ, Krahn M, Wong WWL. Value in Health. 2020 Jan; 23(1): 127-137.
Community pharmacy medication review, death and re-admission after hospital discharge: A propensity score-matched cohort study.
Lapointe-Shaw L, Bell C, Austin P, Abrahamyan L, Ivers NM, Li P, Pechlivanoglou P, Redelmeier DA, Dolovich L. BMJ Quality & Safety. 2020 Jan; 29(1): 41-51.
Cost-utility of early breast cancer surveillance in survivors of thoracic radiation-treated adolescent Hodgkin’s lymphoma.
Tessier L, Furzer J, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Journal of the National Cancer Institute. 2020 Jan 1; 112(1):63-70.
Picturing ELSI+: A visual representation of ethical, legal, and social issues, and patient experiences in Health Technology Assessment in Canada.
Krahn MD, Bremner KE, de Oliveira C, Almeida N, Clement F, Lorenzetti DL, O’Campo P, Pechlivanoglou P, Tricco AC. International Journal of Technology Assessment in Health Care. 2020; 36(1):40-49.

2019

Population-based study of the impact of small bowel obstruction due to adhesions on short- and medium-term mortality.
Behman R, Nathens AB, Haas B, Look Hong N, Pechlivanoglou P, Karanicolas P. The British Journal of Surgery. 2019 Dec; 106(13): 1847-1854.
Effectiveness and safety of primary thromboprophylaxis in children with cancer: A systematic review of the literature and network meta-analysis.
Pelland-Marcotte MC, Tole S, Pechlivanoglou P, Brandao LR. Thrombosis and Haemostasis. 2019 Dec; 119(12): 2034-2042.
Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy.
Widjaja E, Papastavros T, Sander B, Snead C, Pechlivanoglou P. PLoS One. 2019 Nov; 14(11):e0224571.
New insights into the epidemiology of prostate cancer in Ontario.
Abrahamyan L, Huszti E, Bremner KE, Pechlivanoglou P, Mitsakakis N, Krahn M. Cancer Investigation. 2019 Nov; 37(10): 513-523.
Home dialysis is associated with lower costs and better survival than other modalities: A population-based study in Ontario, Canada.
Krahn MD, Bremner KE, de Oliveira C, Dixon S, McFarlane P, Garg A, Mitsakakis N, Blake P, Harvey R, Pechlivanoglou P. Peritoneal Dialysis International. 2019 Nov-Dec; 39(6): 553-561.
A need for change! A coding framework for improving transparency in decision modeling.
Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SZ, Yand A, Enns EA. Pharmacoeconomics. 2019 Nov; 37(11): 1329-1339.
Surgery for adhesive small bowel obstruction is associated with improved long-term survival mediated through recurrence prevention: A population-based, propensity-matched analysis.
Behman R, Nathans A, Haas B, Hong NL, Pechlivanoglou P, Karanaicolas P. Journal of Trauma and Acute Care Surgery. 2019 Sep; 87(3); 636-644.
Antiviral treatment for treatment-naïve chronic hepatitis B: Systematic review and network meta-analysis of randomized controlled trials.
Wong WWL, Pechlivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, Saeed Y, Phoon A, Tadrous M, Younis M, Rayad NZ, Rac V, Janssen HLA, Krahn MD. Systematic Reviews. 2019 Aug; 8(1):207.
Assessment of therapeutic interventions and lung protective ventilation in patients with moderate to severe acute respiratory distress syndrome: A systematic review and network meta-analysis.
Aoyama H, Uchida K, Aoyama K, Pechlivanoglou P, Englesakis M, Yamada Y, Fan E. JAMA Network Open. 2019 Jul; 2(7):e198116.
Innovative approaches to investigator-initiated, multi-centre pediatric clinical trials in Canada.
Kelly LE, Richer L, Ali S, Plint A, Poonai N, Freedman S, Knisley L, Shimmin C, Hickes S, W’tJong G, Pechlivanoglou P, Offringa M, Lacaze T, Klassen TP. BMJ Open. 2019 Jun 27; 9(6):e029024.
Association of surgical intervention for adhesive small-bowel obstruction with the risk of recurrence.
Behman R, Nathens AB, Mason S, Byrne JP, Look Hong N, Pechlivanoglou P, Karanicolas PJ. JAMA Surgery. 2019 May; 154(5):413-420.
The effect of cardiac rehabilitation on health-related quality of life in patients with coronary artery disease: A meta-analysis.
Francis T, Kabboul N, Rac V, Mitsakakis N, Pechlivanoglou P, Bielecki J, Alter D, Krahn M. Canadian Journal of Cardiology. 2019 Mar; 35(3): 352-364.
Chlorhexidine-related mortality rate in critically ill subjects in intensive care units: A systematic review and meta-analysis.
Lee S, Lighvan NL, McCredie V, Pechlivanoglou P, Krahn M, Quiñonez C, Azarpazhooh A. Respiratory Care. 2019 Mar; 64(3):337-349.

2018

Systematic review and network meta-analysis on the relative efficacy of osteoporotic medications: men with prostate cancer on continuous androgen-deprivation therapy to reduce risk of fragility fractures.
Poon Y, Pechlivanoglou P, Alibhai SMH, Naimark D, Hoch JS, Papadimitropoulos E, Hogan ME, Krahn M. BJU Int. 2018 Jan;121(1):17-28.
The Canadian preterm birth network: a study protocol for improving outcomes for preterm infants and their families.
Shah PS, McDonald SD, Barrett J, Synnes A, Robson K, Foster J, Pasquier JC, Joseph KS, Piedboeuf B, Lacaze-Masmonteil T, O’Brien K, Shivananda S, Chaillet N, Pechlivanoglou P. CMAJ Open. 2018 Jan;18:6(1):E44-E49.
Microsimulation modeling for health decision sciences using R: A tutorial.
Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. Med Decis Making. 2018 Apr;38(3):400-22.
Cardiac computed tomography and magnetic resonance imaging vs. transesophageal echocardiography for diagnosing left atrial appendage thrombi.
Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I. Europace. 2018 Jun 28. doi: 10.1093/europace/euy142.
Changes in blood pressure among patients in the Ontario Telehomecare programme: An observational longitudinal cohort study.
Sahakyan Y, Abrahamyan L, Shahid N, Stanimirovic A, Pechlivanoglou P, Mitsakakis N, Ryan W, Krahn M, Rac VE. J Telemed Telecare. 2018 Jul;24(6):420-27.
Evolving management strategies in patients with adhesive small bowel obstruction: A population-based analysis.
Behman R, Nathens AB, Hong NL, Pechlivanoglou P, Karanicolas P. J Gastrointest Surg. 2018 Jul 26. doi: 10.1007/s11605-018-3881-z.
Turning high risk patients: An economic evaluation of repositioning frequency in long-term care.
Pechlivanoglou P, Paulden M, Pham B, Wong J, Horn SD, Krahn M. J Am Geriatr Soc. 2018 Jul;66(7):1409-14.
Diagnostic accuracy of level IV portable sleep monitors versus polysomnography for obstructive sleep apnea: a systematic review and meta-analysis.
Abrahamyan L, Sahakyan Y, Chung S, Pechlivanoglou P, Bielecki J, Carcone SM, Rac VE, Fitzpatrick M, Krahn M. Sleep Breath. 2018 Sep;22(3):593-611.

2017

Corneal collagen cross-linking in the management of keratoconus in Canada: a cost-effectiveness analysis.
Leung V, Pechlivanoglou P, Chew H, Krahn M, Hatch W. Ophthalmology. 2017 Aug;124(8):1108-19.
A comparison of four software programs for implementing decision analytic cost effectiveness models.
Hollman C, Paulden M, Pechlivanoglou P, McCabe C. Pharmacoeconomics. 2017 Aug;35(8):817-30.
An overview of R in health decision sciences.
Jalal H, Pechlivanoglou P, Krijkamp E*, Alarid-Escudero F, Enns E, Hunink MG. Med Decis Making. 2017 Oct;37(7):735-46.

2016

Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: An economic analysis.
Gajic-Veljanoski O, Pham B, Pechlivanoglou P, Krahn M, Higgins C, Bielecki J. Ont Health Technol Assess Ser. 2016 Mar 8;16(8):1-83.
Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease.<
Stevanovíc J, Pechlivanoglou P, Kampinga MA, Krabbe PF, Postma MJ. PLoS One. 2016 Mar 24;11(3):e0152030.
Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM. Osteoporos Int. 2016 May;27(5):1709-18.
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
Amiche A, Albaum J, Tadrous M, Pechlivanoglou P. Osteoporos Int. 2016 Jun;27(6):1989-98.
Using phase-based costing of real-world data to inform decision-analytic models for atrial fibrillation
Tawfik A, Wodchis WP, Pechlivanoglou P, Krahn M. Appl Health Econ and Health Policy. 2016 Jun;14(3):313-22.>
Systematic review and network meta-analysis of stroke-prevention treatment in patients with atrial fibrillation. Clinical Pharmacology: Advances and Applications.
Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Huserau D, Pechlivanoglou P. Clinical Pharmacology: Advances and Applications. 2016 Aug;11(8):93-107.
Uptake of the MedsCheck Annual medication review service in Ontario community pharmacies between 2007 and 2013.
Dolovich L, Consiglio G, MacKeigan L, Arahamyan L, Pechlivanoglou P, Rac VE, Pojskic N, Bojarski EA, Su J, Krahn M, Cadarette SM. CPJ. 2016 Sept;149(5):293-302.
Factors affecting the delivery of community pharmacist-led medication reviews: Evidence from the MedsCheck Annual service in Ontario.
Pechlivanoglou P, Abrahamyan L, Mackeigan, L, Consiglio G, Dolovich L, Li P, Cadarette SM, Rac VE, Shin J, Krahn M. BMC Health Serv Res. 2016 Nov 21;16(1):666.

2015

A practical approach to evidence-based dentistry: IX How to appraise and use an article about economic analysis
Abrahamyan L, Pechlivanoglou P, Krahn M, et al. Journal of American Dental Association. 2015;146(9):679-689.e1.
An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons
Pechlivanoglou P, Yazew AF, Postma MJ, Wit E. Pharmaceutical statistics. 2015 DOI: 10.1002/pst.1688

The effect of financial and educational incentives on rational prescribing. A state-space approach
Pechlivanoglou P, Wieringa JE, Jager T, Postma MJ. Health Economics. 2015 Apr;24(4):439-53
A discrete choice experiment (Dce) to elicit preferences for attributes of a bedside pharmacogenetics test – preliminary results.
Bereza BG, Pechlivanoglou P, Coyle D, Wells G, So D, Grootendorst P, Papadimitropoulos M. Value Health. 2015 Nov;18(7):A399.

2014

After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel E, Hak E. J Clin Epidemiol. 2014 Jul;67(7):734-744
Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension. A scenario analysis for the Netherlands
Stevanovic J, O’Prinsen AC, Postma MJ, Pechlivanoglou P. Clinical Therapeutics. 2014 36(3):368-84
Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons
Roessler R ,Smalwood SA, Veenfiet KV, Pechlivanoglou P, Peng SP, Chakrabarty K, Groot-Koerkamp MJ, Pasterkamp RJ, Wesseling E, Kelsey G, Boddeke E, Smidt MP, Copray S. Stem Cell Reports. 2014 Apr 3;2(4):520-33
Dehydroepi-androsterone sulphate as a putative protective factor against tardive dyskinesia
Ivanova SA, Geers LM, Al Hadithy AFY, Pechlivanoglou P, Semke AV, Vyalova NM, Rudikov EV, Fedorenko OY, Wilffert B, Bokhan NA, Brouwers JR, Loonen AJ. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2014;50(3):172:177
Mixed treatment comparison (MTC) of antifungal prophylactic strategies against invasive fungal infections (IFIs) in patients receiving chemotherapy for haematological malignancies or allogeneic hematopoietic stem cells transplantation
Pechlivanoglou P, Le HH Daenen S, Postma MJ. JAC. 2014;69(1):1-11

2013

Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell cancer in Serbia.
Mihajlović J, Pechlivanoglou P, Sabo A, Tomić Z, et al. Clinical Therapeutics 2013; 35(12):1909-22
Cancer incidence and mortality in Serbia 1999-2009
Mihajlovic J, Pechlivanoglou P, Miladinov-Mikov M, Živković S, et al. BMC Cancer 2013, 13:18
Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time
Parouty MBY, Krooshof DGM, Pechlivanoglou P, Postma MJ. . Expert Reviews in Pharmacoeconomics 2013;13(4):523-47
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis
Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, et al. European Journal of Clinical Microbiology & Infectious Diseases 2013;32(3):305-16

2012

Systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary prevention
Stevanovic J, Postma MJ, Pechlivanoglou P. A . European Journal of Preventive Cardiology 2012, 19(2(S)) 1–12|
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia
Ivanova SA, Loonen A, Pechlivanoglou P, et al. Translational Psychiatry, 2012 2(1):e67

2011

Analyzing generic and branded substitution patterns in the Netherlands using prescription data
Pechlivanoglou P, van der Veen WJ, Bos JH, Postma MJ. BMC Health Service Research. 2011;11(89).
Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence
Pechlivanoglou P, De Vries R, Daenen S, Postma MJ. Pharmacoeconomics. 2011;29(9):737-751.
Diagnostic accuracy of culture-based and PCR-based detection tests for MRSA – a meta-analysis.
Luteijn JM, Hubben GA, Pechlivanoglou P, Bonten MJ, Postma MJ. Clin Microbiol Infect. 2011 Feb;17(2):146-54.

2010

Diffusion of a new drug: adoption, patients’ treatment complexity and persistence of risperidone long-acting injectable (RLAI).
Pechlivanoglou P, Vehof J, van Agthoven M, Postma MJ. Clin Ther. 2010 Jan;32(1):108-18.
Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia.
Al Hadithy AF, Ivanova SA, Pechlivanoglou P, Wilffert B, Semke A, Fedorenko O, Kornetova E, Ryadovaya L, Brouwers JR, Loonen AJ. Hum psychopharmacol. 2010 Jan;25(1):84-91.
Cost Effectiveness of Population-Based ‘Screen-and-Treat’ Strategies for Albuminuria to Prevent Cardiovascular and Renal Disease.
Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ. Clin Ther. 2010 Jun;32(6):1103-21.

2009

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia
Al Hadithy AF, Ivanova SA, Pechlivanoglou P, Semke A, et al.. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):475-81

2008

Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.
Sancar AA, Yegenoglu S, de Vries R, Postma MJ, Simsek N, Pechlivanoglou P, Unal S. Pharm World Sci. 2008 Dec;30(6):916-23
The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.
Hubben GA, Bishai D, Pechlivanoglou P, Cattelan AM, et al. A. AIDS Care. 2008 Apr;20(4):449-55

2007

Statistical analysis of the reports of the Quality of Life department of the Greek Ombudsman
Pechlivanoglou P, Pechlivanoglou K. Review of Administrative Sciences 2007;13 [In Greek (English abstract)]